Variability in human sensitivity to 1,3-butadiene: Influence of the allelic variants of the microsomal epoxide hydrolase gene

Environmental and Molecular Mutagenesis

Volumn 41, Issue 2, 2003, Pages 140-146

  Abdel Rahman, Sherif Z ^a   El Zein, Randa A ^b   Ammenheuser, Marinel M ^a   Yang, Zhen ^a   Stock, Thomas H ^c   Morandi, Maria ^c   Ward Jr , Jonathan B ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Biomarkers; Biomonitoring; Butadiene; Epoxide hydrolase; Genetic susceptibility; HPRT; Multiplex PCR; Polymorphism

Indexed keywords

1,3 BUTADIENE; BIOLOGICAL MARKER; EPOXIDE HYDROLASE; STYRENE;

ADULT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DOSIMETER; FEMALE; GENOTOXICITY; GENOTYPE; HUMAN; LYMPHOCYTE; MALE; MUTAGENICITY; MUTATION; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; RUBBER INDUSTRY;

ALLELES; AMINO ACID SUBSTITUTION; BUTADIENES; DNA PRIMERS; ELASTOMERS; EPOXIDE HYDROLASES; GENOTYPE; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LYMPHOCYTES; MICROSOMES; MIDDLE AGED; MUTAGENICITY TESTS; MUTAGENS; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RUBBER; STYRENES;

EID: 0037223732     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10142     Document Type: Article

References (36)

1. Abdel-Rahman SZ, Nouraldeen AM, Ahmed AE. 1994. Molecular interaction of [2,3-14C] acrylonitrile with DNA in gastric tissue of rat. J Biochem Toxicol 9:191-198.
2. Abdel-Rahman SZ, Ammenheuser MM, Ward JB Jr. 2001. Human sensitivity to 1,3-butadiene: role of microsomal epoxide hydrolase polymorphisms. Carcinogenesis 22:415-423.
3. Ammenheuser MM, Au WW, Whorton, EBJ, Belli JA, Ward JB Jr. 1991. Comparison of hprt variant frequencies and chromosome aberration frequencies in lymphocytes from radiotherapy and chemotherapy patients: a prospective study. Environ Mol Mutagen 18:126-135.
4. Ammenheuser MM, Hastings DA, Whorton EBJ, Ward JB Jr. 1997. Frequencies of hprt mutant lymphocytes in smokers, non-smokers, and former smokers. Environ Mol Mutagen 30:131-138.
5. Ammenheuser MM, Bechtold WE, Abdel-Rahman SZ, Rosenblatt JI, Hastings-Smith DA, Ward JB Jr. 2001. Assessment of 1,3-butadiene exposure in polymer production workers using hprt mutation in lymphocytes as a biomarker. Environ Health Perspect 109:1249-1255.
6. Benhamou S, Reinikainen M, Bouchardy, C, Dayer P, Hirvonen A. 1998. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res 58:5291-5293.
7. Chung CW, Morandi MT, Stock TH, Afshar M. 1999. Evaluation of a passive sampler for volatile organic compounds at ppb concentrations, varying temperatures and humidities with 24-hour exposures. 11. Sampler performance. Environ Sci Tech 33:66-367.
8. Cochrane JE, Skopek TR. 1994. Mutagenicity of butadiene and its epoxide metabolites. I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 15:713-717.
9. Duescher RJ, Elfarra AA. 1994. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. Arch Biochem Biophys 311:342-349.
10. Harrison DJ, Hubbard AL, MacMillan J, Wyllie AH, Smith CA. 1999. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer 79:168-171.
11. Hasset C, Aicher L, Sidhu JS, Omiecinski, CJ. 1994. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3:421-428.
12. Hasset C, Aicher L, Sidhu JS, Omiecinski, CI. 1997. Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Arch Biochem Biophys 337:275-283.
13. Hayes RB, Zhang L, Yin S, Swenberg JA, Xi L, Wiencke J, Bechtold WE, Yao M, Rothman N, Haas R, O'Neill JP, Zhang D, Wiemels J, Dosemeci M, Li G, Smith MT. 2000. Genotoxic markers among butadiene polymer workers in China. Carcinogenesis 21:55-62.
14. Henderson RF, Thornton-Manning JR, Bechtold WE, Dahl AR. 1996. Metabolism of 1,3-butadiene: species differences. Toxicology 113:17-22.
15. IARC. 1992. Occupational exposures to mists and vapors from strong inorganic acids and other industrial chemicals. Lyon: International Agency for Research on Cancer.
16. Jackson MA, Stack FH, Rice JM, Waters MD. 2000. A review of the genetic and related effects of 1,3-butadiene in rodents and humans. Mutat Res 463:181-213.
17. Kelsey KT, Wiencke JK, Ward JB Jr, Bechtold W, Fajen J. 1995. Sisterchromatid exchanges, glutathione S-transferase theta deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutat Res 335:267-273
18. Kitteringham NR, Davis C, Howard N, Pirmohamed M, Park BK. 1996. Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamezine 10,11-epoxide and naphthalene. J Pharmacol Exp Ther 278:1018-1027.
19. London SJ, Smart J, Daly AK. 2000. Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County. Lung Cancer 28:147-155.
20. Ma H, Wood T, Ammenheuser MM, Rosenblatt JI, Ward JB Jr. 2000. Molecular analysis of hprt mutant lymphocytes from 1,3-butadiene-exposure of workers, Environ Mol Mutagen 18:126-135.
21. McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, Zhou T, Wild CP, Xia XL, Baffoe-Bonnie A, Ofori-Adjei D, Chen G-C, London T, Shen F-M, Buetow KH. 1995. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA 92:2384-2387.
22. Meng Q, Henderson RF, Walker DM, Bauer MJ, Reilly AA, Walker VE. 1999. Mutagenicity of the racemic mixtures of butadiene monoepoxide and butadiene diepoxide at the hprt locus of T-lymphocytes following inhalation exposures of female mice and rats. Mutat Res 429:127-140.
23. NTP (National Toxicology Program). 2001. 9th Report on Carcinogens, 1,3-Butadiene CAS No. 106-99-0, U.S. Department of Health and Human Services, Public Health Service.
24. Pastorelli R, Guanci M, Cerri A, Negri E, La Vecchia C, Fumagalli F, Mezzetti M, Cappelli R, Panigalli T, Fanelli R, Airoldi L. 1998. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene diolepoxide. Cancer Epidemiol Biomark Prev 7:703-709.
25. Seaton MJ, Follansbee MH, Bond JA. 1995. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis 16:2287-2293.
26. Smith CA, Harrison DJ. 1997. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema [see Comments]. Lancet 350:630-633.
27. Sorsa M, Osterman-Golkar S, Peltonen K, Saarikoski ST, Sram R. 1996. Assessment of exposure to butadiene in the process industry. Toxicology 113:77-83.
28. Sram RJ, Rossner P, Peltonen K, Podrazilova K, Mrackova G, Demopoulos NA, Stephanou G, Vlachodimitropoulos D, Darroudi F, Tates AD. 1998. Chromosomal aberrations, sister-chromatid exchanges, cells with high frequency of SCE, micronuclei and comet assay parameters in 1,3-butadiene-exposed workers. Mutat Res 419:145-154.
29. Steen AM, Meyer KG, Recio L. 1997. Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane. Mutagenesis 12:61-67.
30. Swenberg JA, Koc H, Upton PB, Georguieva N, Ranasinghe A, Walker V, Henderson R. 2001. Using DNA and hemoglobin adducts to improve the risk assessment of butadiene. Chemico-Biol Interact 135-136:387-403.
31. Uuskula M, Jarventaus H, Hirvonen A, Sorsa M, Norppa H. 1995. Influence of GSTM1 genotype on sister chromatid exchange induction by styrene-7,8-oxide and 1,2-epoxy-3-butene in cultured human lymphocytes. Carcinogenesis 16:947-950.
32. Van Vunakis H, Gjika HB, Langone JJ. 1993. Radioimmunoassay for nicotine and cotinine. In: O'Neill KD, editor. Genetic changes in lung cancer. J Cell Biochem Suppl 17F:237-248.
33. Ward JB Jr, Ammenheuser MM, Bechtold WE, Whorton EBJ, Legator MS. 1994. Hprt mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant. Environ Health Perspect 102:79-85.
34. Ward JB Jr, Ammenheuser MM, Whorton EB, Bechtold WE, Kelsey KT, Legator MS. 1996. Biological monitoring for mutagenic effects of occupational exposure to butadiene. Toxicology 113:84-90.
35. Ward JB Jr, Abdel-Rahman SZ, Henderson RF, Stock TH, Morandi M, Rosenblatt JI, Ammenheuser MM. 2001. Assessment of butadiene exposure in synthetic rubber manufacturing workers in Texas using frequencies of hprt mutant lymphocytes as a biomarker. Chemico-Biol Interact 135/136:465-483.
36. Wiencke JK, Pemble S, Ketterer B, Kelsey KT. 1995. Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomark Prev 4:253-259.